0001140361-21-017512.txt : 20210514
0001140361-21-017512.hdr.sgml : 20210514
20210514202643
ACCESSION NUMBER: 0001140361-21-017512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210512
FILED AS OF DATE: 20210514
DATE AS OF CHANGE: 20210514
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Merton Carl A
CENTRAL INDEX KEY: 0001860546
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 21927030
MAIL ADDRESS:
STREET 1: C/O TILRAY, INC.
STREET 2: 745 FIFTH AVENUE, SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 824310622
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
BUSINESS PHONE: 519.322.8800
MAIL ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
4
1
form4.xml
FORM 4
X0306
4
2021-05-12
0001731348
Tilray, Inc.
TLRY
0001860546
Merton Carl A
C/O TILRAY, INC.
745 FIFTH AVENUE, SUITE 1602
NEW YORK
NY
10151
true
Chief Financial Officer
Class 2 Common Stock
2021-05-12
4
S
0
89000
14.82
D
169105
D
The shares were sold to satisfy tax obligations of the reporting person incurred in connection with the closing of the plan of arrangement (the "Arrangement") between Tilray, Inc. and Aphria Inc. on April 30, 2021, pursuant to which each common share of Aphria Inc. was exchanged for 0.8381 of a share of Class 2 common stock of Tilray, Inc.. The Arrangement was considered a taxable event for Canadian shareholders of Aphria Inc.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from CAD $17.80 to CAD $18.10, inclusive. The reporting person undertakes to provide to Tilray, Inc. any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). The weighted average price reported above was converted from the Canadian weighted average price of CAD $17.9857 to USD using an exchange rate of CAD $1.2133=USD $1.00.
/s/ Carl A. Merton
2021-05-14